Scanfil Oyj
2.3.2021 09:31:46 CET | Globenewswire | Press release
SCANFIL PLC MANAGERS' TRANSACTIONS 2 March 2021 10.30 A.M.
Scanfil Plc - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Kristoffer Asklöv
Position: Other senior manager
Issuer: Scanfil Oyj
LEI: 7437004XD6U0FFDCT507
Notification type: INITIAL NOTIFICATION
Reference number: 7437004XD6U0FFDCT507_20210301185930_2
____________________________________________
Transaction date: 2021-03-01
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000029905
Nature of the transaction: DISPOSAL
Transaction details
(1): Volume: 861 Unit price: 7.42 EUR
(2): Volume: 129 Unit price: 7.42 EUR
(3): Volume: 1 Unit price: 7.42 EUR
(4): Volume: 560 Unit price: 7.4 EUR
(5): Volume: 581 Unit price: 7.4 EUR
(6): Volume: 635 Unit price: 7.4 EUR
(7): Volume: 13 Unit price: 7.4 EUR
(8): Volume: 5,220 Unit price: 7.4 EUR
Aggregated transactions
(8): Volume: 8,000 Volume weighted average price: 7.40248 EUR
SCANFIL PLC
Petteri Jokitalo
CEO
For additional information:
CEO Petteri Jokitalo
tel. +358 8 4882 111
www.scanfil.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S3.10.2026 21:40:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer
Chery Group3.10.2026 14:28:18 CEST | Press release
FREELANDER Marks a New Chapter at Its Global Brand Launch in Abu Dhabi
Chery Group3.10.2026 14:16:10 CEST | Press release
FREELANDER Sets Out Its International Roadmap with a Phased Expansion from the Middle East
Chery Auto3.10.2026 10:47:01 CEST | Press release
LEPAS Enters Romania: LEPAS L8 PHEV Officially Launches as First Flagship Store Opens
Novo Nordisk A/S2.10.2026 22:53:42 CEST | Press release
Novo provides update on the denecimig Biologics License Application (BLA) in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
